Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 in Recurrent/Metastatic SCCHN
NCT01527877Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buparlisib in head and neck squamous cell carcinoma (HNSCC), sponsored by Yonsei University. Status: unknown.
02
Drugs
buparlisib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01527877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527877.